← Back to headlines





BioNTech Faces Economic Challenges After COVID Vaccine Success
BioNTech, the company behind a major COVID-19 vaccine, is reportedly facing an 'end of an era' as it navigates economic challenges, cuts, and closures after its pandemic-era billions. The company is now placing a significant bet on its cancer research.
14 May, 18:21 — 14 May, 18:21
Coverage Timeline
First report: protothema-en · 14 May, 18:21|Full coverage: 2 · 57m|Window: 57m
Left-leaningCenterRight-leaning
Related Stories

Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now

Reduced Grid Service Costs Lower May Electricity Rates in Zambales
just now

Xi Jinping tells US tech CEOs China's economy will open further
12m ago

Nigerian Government plans AI-powered intelligence system for security
13m ago